]>
IRCT2014112520087N1 IRCT 2015-05-24 Vice Chanceller for research of Ardabil University of Medical Sciences Examine the complementary effects of omega lipid on lipid profile serum and compare it with effect of placebo of omega in patients With Chronic dialysis. - Evaluation of the effect of omega-3 supplimentation on serum lipid in patients with chronic dialysis 2014-12-06 anticipated 60 Complete https://irct.ir/trial/17835 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Other design features: Patients of omega and placebo groups will be selected randomly. Omega group patients will select among patients dialysis on Saturday, Monday and Wednesday and placebo group patients will select among patients dialysis on Sunday, Tuesday and Thursday. N/A End stage renal disease. Intervention 1: Control: Daily one placebo of Omega Max made in Zahravi Pharmaceutical Company for three months Prescribed. Intervention 2: Intervention group: Daily one Omega Max Capsule made in Zahravi Pharmaceutical Company containing 400 mg Eicosapentanoic Acid and 300 mg Decosa Hexanoic Acid for three months prescribed.
public Dr. Bahman Bashardoost
Ardabil Emam Khomeini Hospital, Shahid Jeddi Street.
Ardabil Iran (Islamic Republic of) - +98 45332514018 bahman.bashardoost@arums.ac.ir Ardabil University of Medical Sciences scientific Dr. Bahman Bashardoost
Ardabil Emam Khomeini Hospital - Shahid jeddi Street.
Ardabil Iran (Islamic Republic of) - +98 45332514018 bahman.bashardoost@arums.ac.ir Ardabil university of medical sciences Iran (Islamic Republic of) Inclusion criteria: Patients that have been receive dialysis therapy for more than three months؛ patients that have been received no anti-lipid drugs as yet. Exclusion criteria for the study: Patients that can’t tolerate drugs receive؛ patients not interested in drugs receive؛ patients die during intervention. no limit no limit Both N18 Chronic kidney disease Placebo Prevention Control: Daily one placebo of Omega Max made in Zahravi Pharmaceutical Company for three months Prescribed. Intervention group: Daily one Omega Max Capsule made in Zahravi Pharmaceutical Company containing 400 mg Eicosapentanoic Acid and 300 mg Decosa Hexanoic Acid for three months prescribed. High Density Lipoprotein (HDL). Timepoint: Before and three months after intervention. Method of measurement: Laboratory measurement of serum HDL concentrations in scale mili mol / lit. Low Density Lipoprotein (lDL). Timepoint: Before and three months after intervention. Method of measurement: Laboratory measurement of serum LDL concentrations in scale mili mol / lit. Triglyceride(TG). Timepoint: Before and three months after intervention. Method of measurement: Laboratory measurement of serum TG concentrations in scale mili mol / lit. Cross Reacting Protein (CRP). Timepoint: Before intervention, three months after intervention. Method of measurement: Laboratory measurement of serum CRP concentrations in scale Mg / dl. Vice Chanceller for research of Ardabil University of Medical Sciences Approved 2014-07-27 Ardabil University Of Medical Sciences Ardabil University Of Medical Sciences, Daneshgah Street. Ardabil Iran (Islamic Republic of)